Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Oncogene

• Publication date

  2013-10-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2012.558PMID 23178495
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 3. Mechanisms Relating Estrogens to Breast Cancer

  2012cited by this paper
• Comparison of increased aromatase versus ERα in the generation of mammary hyperplasia and cancer.

  2011cited by this paper
• Exemestane for breast-cancer prevention in postmenopausal women.

  2011cited by this paper
• Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms

  2010cited by this paper
• Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling

  2010cited by this paper
• Progesterone induces adult mammary stem cell expansion

  2010cited by this paper
• Control of mammary stem cell function by steroid hormone signalling

  2010cited by this paper
• Risk factors for ductal and lobular breast cancer: results from the nurses' health study

  2010cited by this paper
• Urine Biomarkers of Risk in the Molecular Etiology of Breast Cancer

  2009cited by this paper
• Aromatase expression is increased in BRCA1 mutation carriers

  2009cited by this paper
• Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

  2009cited by this paper
• The molecular etiology of breast cancer: Evidence from biomarkers of risk

  2007cited by this paper
• Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition.

  2007cited by this paper
• Long-term Treatment with Tamoxifen Facilitates Translocation of Estrogen Receptor α out of the Nucleus and Enhances its Interaction with EGFR in MCF-7 Breast Cancer Cells

  2007cited by this paper
• Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells.

  2007cited by this paper
• Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: role of reactive oxygen and biological selection.

  2006cited by this paper
• CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis

  2006cited by this paper
• BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.

  2006cited by this paper
• 17‐Beta‐Estradiol induces transformation and tumorigenesis in human breast epithelial cells

  2006cited by this paper
• Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.

  2006cited by this paper
• Estrogen carcinogenesis in breast cancer.

  2006cited by this paper
• Unopposed estrogen therapy and the risk of invasive breast cancer.

  2006cited by this paper
• Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression

  2005cited by this paper
• Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

  2005cited by this paper
• Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition.

  2005cited by this paper
• Diagnosis and surgical removal of a granulosa-theca cell tumor in a mare.

  2005cited by this paper
• A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.

  2005cited by this paper
• Estrogen Receptor Status in BRCA1- and BRCA2-Related Breast Cancer

  2004cited by this paper
• Relative imbalances in estrogen metabolism and conjugation in breast tissue of women with carcinoma: potential biomarkers of susceptibility to cancer.

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways.

  2003cited by this paper
• 17Beta-estradiol is carcinogenic in human breast epithelial cells.

  2002cited by this paper
• Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies.

  2002cited by this paper
• The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

  2002cited by this paper
• Activation of the MAPK pathway enhances sensitivity of MCF-7 breast cancer cells to the mitogenic effect of estradiol.

  2002cited by this paper
• 17β-Estradiol is carcinogenic in human breast epithelial cells

  2002cited by this paper
• Chapter 1: Developmental, Cellular, and Molecular Basis of Human Breast Cancer

  2000cited by this paper
• Developmental, cellular, and molecular basis of human breast cancer.

  2000cited by this paper
• In situ aromatization enhances breast tumor estradiol levels and cellular proliferation.

  1998cited by this paper
• Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.

  1996cited by this paper
• Overexpression of int-5/aromatase in mammary glands of transgenic mice results in the induction of hyperplasia and nuclear abnormalities.

  1996cited by this paper
• A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription.

  1993cited by this paper
• Stable expression of human aromatase complementary DNA in mammalian cells: a useful system for aromatase inhibitor screening.

  1990cited by this paper
• Aromatase activity in adipose tissue from breast quadrants: A link with tumor site

  1989cited by this paper
• Aromatase activity in adipose tissue from breast quadrants: a link with tumour site

  1988cited by this paper
• Increased aromatase activity in pubic skin fibroblasts from patients with isolated gynecomastia.

  1987cited by this paper
• Familial gynecomastia with increased extraglandular aromatization of plasma carbon19-steroids.

  1985cited by this paper
• Menopause and breast cancer risk.

  1972cited by this paper
• Breast cancer and artificial menopause: a cohort study.

  1968cited by this paper
• Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice.

  1959cited by this paper

• Application of the Magnet-Cre optogenetic system in the chicken model.

  2025cites this paper
• Review Article: The Biochemical Role Of Environmental Pollution In The Etiology Of Endometriosis

  2024cites this paper
• GPR39-mediated ERK1/2 signaling reduces permethrin-induced proliferation of estrogen receptor α-negative cells.

  2024cites this paper
• The Breast Cancer Stem Cells Traits and Drug Resistance

  2021cites this paper
• Synthesis of new α-Aryl-α-tetralones and α-Fluoro-α-aryl-α-tetralones, preliminary antiproliferative evaluation on drug resistant cell lines and in silico prediction of ADMETox properties.

  2021cites this paper
• Plasma membrane localization of CYP4Z1 and CYP19A1 and the detection of anti-CYP19A1 autoantibodies in humans.

  2019cites this paper
• CYP17 polymorphisms are associated with decreased risk of breast cancer in Chinese Han women: a case–control study

  2018cites this paper
• Clinical Significance of Peripheral Blood PCA3 Gene Expression in Early Diagnosis of Prostate Cancer

  2018cites this paper
• Aromatase Acetylation Patterns and Altered Activity in Response to Sirtuin Inhibition

  2018cites this paper
• Anti-proliferative and pro-apoptotic effects of rosemary and constituent terpenoids in a model for the HER-2-enriched molecular subtype of clinical breast cancer.

  2018cites this paper
• DVL1 and DVL3 differentially localize to CYP19A1 promoters and regulate aromatase mRNA in breast cancer cells

  2018influential citation
• PFOS induces proliferation, cell-cycle progression, and malignant phenotype in human breast epithelial cells

  2017cites this paper
• Leptin induces CREB-dependent aromatase activation through COX-2 expression in breast cancer cells.

  2017cites this paper
• Diverse Roles of SIRT1 in Cancer Biology and Lipid Metabolism

  2015cites this paper
• Estrogen withdrawal, increased breast cancer risk and the KRAS-variant

  2015cites this paper
• Arsenic-induced cancer cell phenotype in human breast epithelia is estrogen receptor-independent but involves aromatase activation

  2014cites this paper
• SERMs Attenuate Estrogen-Induced Malignant Transformation of Human Mammary Epithelial Cells by Upregulating Detoxification of Oxidative Metabolites

  2014cites this paper
• Targeting breast cancer initiating cells: advances in breast cancer research and therapy.

  2014cites this paper
• Modulation of Estrogen Metabolism by Hops Extracts and Bioactive Compounds as Analyzed by LC-MS-MS

  2013cites this paper
• Kisspeptin/KISS1R System in Breast Cancer

  2013cites this paper
• Kisspeptin/kiss1r System in Breast Cancer

  year unknowncites this paper